HCA Healthcare (HCA) Fundamental Analysis: Revenue, Earnings & Valuation

2.21 / 10

Underperform

Fundamental rating is Underperform with a 2.2/10 score. Revenue‑MV and total profit growth are strengths, while PB‑ROE and earnings‑per‑share growth are weak. Factor evaluations assign bullish marks to Revenue‑MV and Asset‑MV, but bearish to PB‑ROE and EPS metrics.

Analysis Checks(3/10)

Revenue-MV

Value0.90

Score2/3

Weight19.03%

1M Return3.56%

Net cash flow from operating activities per share (YoY growth rate %)

Value33.76

Score1/3

Weight7.60%

1M Return1.59%

Inventory turnover ratio

Value6.71

Score1/3

Weight2.61%

1M Return0.57%

PB-ROE

Value0.82

Score1/3

Weight1.08%

1M Return0.21%

Basic earnings per share (YoY growth rate %)

Value28.87

Score1/3

Weight3.81%

1M Return0.76%

Total profit (YoY growth rate %)

Value15.36

Score2/3

Weight14.86%

1M Return3.02%

Net cash flow from operating activities (YoY growth rate %)

Value20.18

Score1/3

Weight2.27%

1M Return0.48%

Diluted earnings per share (YoY growth rate %)

Value28.77

Score1/3

Weight2.50%

1M Return0.50%

Asset-MV

Value-0.55

Score2/3

Weight41.31%

1M Return6.60%

Net profit attributable to parent company shareholders (YoY growth rate %)

Value17.78

Score1/3

Weight4.93%

1M Return1.05%

Is HCA fundamentally strong?

HCA scores 2.21/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, 10.29% net margin, 15.55 P/E ratio, -38.07 P/B ratio, and 28.87% earnings growth, these metrics solidify its Underperform investment rating.